Dutch impact investing fund manager Rubio Impact Ventures has reached its first closing of the new fund at €55 million which includes a €2.5 million investment from CANDRIAM’s private equity fund Candriam Impact One. Rubio aims to further accelerate entrepreneurs with game changing solutions as it strongly believes that the most valuable companies of our time will be those solving society’s biggest problems.
This is the second investment from CANDRIAM Impact One since its first close in June this year. Candriam Impact One gives its investors exposure, via investment funds and co-investments, to companies whose performance is linked to measureable social or environmental factors. The fund exclusively invests in European businesses that support areas of need, including access to healthcare, education and employment as well as targets companies that support an inclusive economy and contribute to responsible production and consumption efforts.
The Rubio fund’s first closing continues to receive strong support from the strategic investors such as European Investment Fund with a €20 million participation, as well as a €10m SEED Capital loan from Dutch RVO, and continued support since Fund I from Dutch insurer ASR.
With a packed deal pipeline, the target for Rubio’s second fund is to double in fund size while continuing to invest in the most ambitious early growth stage entrepreneurs who are changing industries for the better. Rubio sees profit and purpose as a virtuous circle and the fund holds itself accountable for ambitious financial and impact targets. Rubio will continue to fundraise for a final close and aims for €140 million under management in 2021.
About Rubio Impact Ventures: Rubio Impact Ventures was founded by Helmer Schukken, Warner Philips, Machtelt Groothuis and Willemijn Verloop. Rubio invests growth capital from €1-8 million in ‘iconic’ game changing ventures such as SkinVision, Van der Sat, OLIO and Samasource.